<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2017-05-10" version="214">
<accession>P09619</accession>
<accession>B5A957</accession>
<accession>Q8N5L4</accession>
<name>PGFRB_HUMAN</name>
<protein>
<recommendedName>
<fullName>Platelet-derived growth factor receptor beta</fullName>
<shortName>PDGF-R-beta</shortName>
<shortName>PDGFR-beta</shortName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Beta platelet-derived growth factor receptor</fullName>
</alternativeName>
<alternativeName>
<fullName>Beta-type platelet-derived growth factor receptor</fullName>
</alternativeName>
<alternativeName>
<fullName>CD140 antigen-like family member B</fullName>
</alternativeName>
<alternativeName>
<fullName>Platelet-derived growth factor receptor 1</fullName>
<shortName>PDGFR-1</shortName>
</alternativeName>
<cdAntigenName>CD140b</cdAntigenName>
</protein>
<gene>
<name type="primary">PDGFRB</name>
<name type="synonym">PDGFR</name>
<name type="synonym">PDGFR1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="3435" last="3439">
<title>Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class.</title>
<authorList>
<person name="Gronwald R.G.K."/>
<person name="Grant F.J."/>
<person name="Haldeman B.A."/>
<person name="Hart C.E."/>
<person name="O'Hara P.J."/>
<person name="Hagen F.S."/>
<person name="Ross R."/>
<person name="Bowen-Pope D.F."/>
<person name="Murray M.J."/>
</authorList>
<dbReference type="PubMed" id="2835772"/>
<dbReference type="DOI" id="10.1073/pnas.85.10.3435"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION AS PDGFB RECEPTOR</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>INTERACTION WITH PDGFB</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1988" name="Mol. Cell. Biol." volume="8" first="3476" last="3486">
<title>cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules.</title>
<authorList>
<person name="Claesson-Welsh L."/>
<person name="Eriksson A."/>
<person name="Moren A."/>
<person name="Severinsson L."/>
<person name="Ek B."/>
<person name="Oestman A."/>
<person name="Betsholtz C."/>
<person name="Heldin C.-H."/>
</authorList>
<dbReference type="PubMed" id="2850496"/>
<dbReference type="DOI" id="10.1128/MCB.8.8.3476"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION AS PDGFB RECEPTOR</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>GLYCOSYLATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>INTERACTION WITH PDGFA AND PDGFB</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2008" name="Arthritis Res. Ther." volume="10" first="R73" last="R73">
<title>Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.</title>
<authorList>
<person name="Jin P."/>
<person name="Zhang J."/>
<person name="Sumariwalla P.F."/>
<person name="Ni I."/>
<person name="Jorgensen B."/>
<person name="Crawford D."/>
<person name="Phillips S."/>
<person name="Feldmann M."/>
<person name="Shepard H.M."/>
<person name="Paleolog E.M."/>
</authorList>
<dbReference type="PubMed" id="18593464"/>
<dbReference type="DOI" id="10.1186/ar2447"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="431" first="268" last="274">
<title>The DNA sequence and comparative analysis of human chromosome 5.</title>
<authorList>
<person name="Schmutz J."/>
<person name="Martin J."/>
<person name="Terry A."/>
<person name="Couronne O."/>
<person name="Grimwood J."/>
<person name="Lowry S."/>
<person name="Gordon L.A."/>
<person name="Scott D."/>
<person name="Xie G."/>
<person name="Huang W."/>
<person name="Hellsten U."/>
<person name="Tran-Gyamfi M."/>
<person name="She X."/>
<person name="Prabhakar S."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chan Y.M."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Martinez D."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nandkeshwar R."/>
<person name="Noonan J.P."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Priest J."/>
<person name="Ramirez L."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="Dickson M."/>
<person name="Cheng J.-F."/>
<person name="Eichler E.E."/>
<person name="Olsen A."/>
<person name="Pennacchio L.A."/>
<person name="Rokhsar D.S."/>
<person name="Richardson P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
</authorList>
<dbReference type="PubMed" id="15372022"/>
<dbReference type="DOI" id="10.1038/nature02919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT PHE-180</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="Oncogene" volume="15" first="1051" last="1057">
<title>Integration of proviral DNA into the PDGF beta-receptor gene in HTLV-I-infected T-cells results in a novel tyrosine kinase product with transforming activity.</title>
<authorList>
<person name="Chi K.D."/>
<person name="McPhee R.A."/>
<person name="Wagner A.S."/>
<person name="Dietz J.J."/>
<person name="Pantazis P."/>
<person name="Goustin A.S."/>
</authorList>
<dbReference type="PubMed" id="9285559"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201267"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 548-569</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2012" name="Genes Chromosomes Cancer" volume="51" first="54" last="65">
<title>Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative neoplasm.</title>
<authorList>
<person name="Chmielecki J."/>
<person name="Peifer M."/>
<person name="Viale A."/>
<person name="Hutchinson K."/>
<person name="Giltnane J."/>
<person name="Socci N.D."/>
<person name="Hollis C.J."/>
<person name="Dean R.S."/>
<person name="Yenamandra A."/>
<person name="Jagasia M."/>
<person name="Kim A.S."/>
<person name="Dave U.P."/>
<person name="Thomas R.K."/>
<person name="Pao W."/>
</authorList>
<dbReference type="PubMed" id="21938754"/>
<dbReference type="DOI" id="10.1002/gcc.20930"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 559-1106 (ISOFORM 1)</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH CEP85L</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1988" name="Cell" volume="55" first="655" last="661">
<title>Tandem linkage of human CSF-1 receptor (c-fms) and PDGF receptor genes.</title>
<authorList>
<person name="Roberts W.M."/>
<person name="Look A.T."/>
<person name="Roussel M.F."/>
<person name="Sherr C.J."/>
</authorList>
<dbReference type="PubMed" id="2846185"/>
<dbReference type="DOI" id="10.1016/0092-8674(88)90224-3"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1046-1106</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Protein Sci." volume="13" first="2819" last="2824">
<title>Signal peptide prediction based on analysis of experimentally verified cleavage sites.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Henzel W.J."/>
</authorList>
<dbReference type="PubMed" id="15340161"/>
<dbReference type="DOI" id="10.1110/ps.04682504"/>
</citation>
<scope>PROTEIN SEQUENCE OF 33-47</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1989" name="Cell" volume="58" first="1121" last="1133">
<title>Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins.</title>
<authorList>
<person name="Kazlauskas A."/>
<person name="Cooper J.A."/>
</authorList>
<dbReference type="PubMed" id="2550144"/>
<dbReference type="DOI" id="10.1016/0092-8674(89)90510-2"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-751 AND TYR-857</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="8314" last="8318">
<title>Independent expression of human alpha or beta platelet-derived growth factor receptor cDNAs in a naive hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways.</title>
<authorList>
<person name="Matsui T."/>
<person name="Pierce J.H."/>
<person name="Fleming T.P."/>
<person name="Greenberger J.S."/>
<person name="LaRochelle W.J."/>
<person name="Ruggiero M."/>
<person name="Aaronson S.A."/>
</authorList>
<dbReference type="PubMed" id="2554309"/>
<dbReference type="DOI" id="10.1073/pnas.86.21.8314"/>
</citation>
<scope>FUNCTION AS PDGFB RECEPTOR IN CELL PROLIFERATION AND CHEMOTAXIS</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1991" name="Cell Regul." volume="2" first="413" last="425">
<title>Functions of the major tyrosine phosphorylation site of the PDGF receptor beta subunit.</title>
<authorList>
<person name="Kazlauskas A."/>
<person name="Durden D.L."/>
<person name="Cooper J.A."/>
</authorList>
<dbReference type="PubMed" id="1653029"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION; ACTIVATION OF PLCG1 AND IN PHOSPHORYLATION OF PLCG1 AND RASA1/GAP</scope>
<scope>MUTAGENESIS OF TYR-751 AND TYR-857</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="8987" last="8992">
<title>Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation.</title>
<authorList>
<person name="Kelly J.D."/>
<person name="Haldeman B.A."/>
<person name="Grant F.J."/>
<person name="Murray M.J."/>
<person name="Seifert R.A."/>
<person name="Bowen-Pope D.F."/>
<person name="Cooper J.A."/>
<person name="Kazlauskas A."/>
</authorList>
<dbReference type="PubMed" id="1709159"/>
</citation>
<scope>INTERACTION WITH PDGFRA; PDGFA AND PDGFB</scope>
<scope>FUNCTION AS RECEPTOR FOR PDGFA AND PDGFB</scope>
<scope>PHOSPHORYLATION AT TYR-857 AND TYR-751</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1991" name="J. Cell Biol." volume="112" first="469" last="478">
<title>Effect of receptor kinase inactivation on the rate of internalization and degradation of PDGF and the PDGF beta-receptor.</title>
<authorList>
<person name="Sorkin A."/>
<person name="Westermark B."/>
<person name="Heldin C.H."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="1846866"/>
<dbReference type="DOI" id="10.1083/jcb.112.3.469"/>
</citation>
<scope>FUNCTION AS RECEPTOR FOR PDGFA AND PDGFB</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF LYS-634</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1992" name="EMBO J." volume="11" first="1373" last="1382">
<title>Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo.</title>
<authorList>
<person name="Kashishian A."/>
<person name="Kazlauskas A."/>
<person name="Cooper J.A."/>
</authorList>
<dbReference type="PubMed" id="1314164"/>
</citation>
<scope>FUNCTION IN ACTIVATION OF PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY</scope>
<scope>INTERACTION WITH PIK3R1 AND RASA1</scope>
<scope>PHOSPHORYLATION AT TYR-740; TYR-751; TYR-771 AND TYR-857</scope>
<scope>MUTAGENESIS OF LYS-634; TYR-716; TYR-740; TYR-751; TYR-763; TYR-771; TYR-775; TYR-778 AND TYR-857</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1992" name="EMBO J." volume="11" first="3911" last="3919">
<title>Identification of two C-terminal autophosphorylation sites in the PDGF beta-receptor: involvement in the interaction with phospholipase C-gamma.</title>
<authorList>
<person name="Ronnstrand L."/>
<person name="Mori S."/>
<person name="Arridsson A.K."/>
<person name="Eriksson A."/>
<person name="Wernstedt C."/>
<person name="Hellman U."/>
<person name="Claesson-Welsh L."/>
<person name="Heldin C.H."/>
</authorList>
<dbReference type="PubMed" id="1396585"/>
</citation>
<scope>FUNCTION AS PDGFB RECEPTOR IN CELL PROLIFERATION AND PHOSPHORYLATION OF PLCG1</scope>
<scope>INTERACTION WITH PLCG1</scope>
<scope>PHOSPHORYLATION AT TYR-1009 AND TYR-1021</scope>
<scope>MUTAGENESIS OF TYR-1009 AND TYR-1021</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="6429" last="6434">
<title>Ligand-induced polyubiquitination of the platelet-derived growth factor beta-receptor.</title>
<authorList>
<person name="Mori S."/>
<person name="Heldin C.H."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="1313434"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEGRADATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1992" name="Mol. Cell. Biol." volume="12" first="2534" last="2544">
<title>GTPase-activating protein and phosphatidylinositol 3-kinase bind to distinct regions of the platelet-derived growth factor receptor beta subunit.</title>
<authorList>
<person name="Kazlauskas A."/>
<person name="Kashishian A."/>
<person name="Cooper J.A."/>
<person name="Valius M."/>
</authorList>
<dbReference type="PubMed" id="1375321"/>
<dbReference type="DOI" id="10.1128/MCB.12.6.2534"/>
</citation>
<scope>INTERACTION WITH PIK3R1 AND RASA1</scope>
<scope>MUTAGENESIS OF TYR-740; TYR-751 AND TYR-771</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1993" name="EMBO J." volume="12" first="2257" last="2264">
<title>Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor; involvement in the interaction with Src family tyrosine kinases.</title>
<authorList>
<person name="Mori S."/>
<person name="Ronnstrand L."/>
<person name="Yokote K."/>
<person name="Engstrom A."/>
<person name="Courtneidge S.A."/>
<person name="Claesson-Welsh L."/>
<person name="Heldin C.H."/>
</authorList>
<dbReference type="PubMed" id="7685273"/>
</citation>
<scope>FUNCTION AS PDGFB RECEPTOR IN CELL PROLIFERATION</scope>
<scope>PHOSPHORYLATION AT TYR-579 AND TYR-581; INTERACTION WITH SRC</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF TYR-579 AND TYR-581</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="3625" last="3631">
<title>Mechanism of platelet-derived growth factor (PDGF) AA, AB, and BB binding to alpha and beta PDGF receptor.</title>
<authorList>
<person name="Fretto L.J."/>
<person name="Snape A.J."/>
<person name="Tomlinson J.E."/>
<person name="Seroogy J.J."/>
<person name="Wolf D.L."/>
<person name="LaRochelle W.J."/>
<person name="Giese N.A."/>
</authorList>
<dbReference type="PubMed" id="7679113"/>
</citation>
<scope>INTERACTION WITH DGFA AND PDGFB</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="21478" last="21481">
<title>Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor.</title>
<authorList>
<person name="Lechleider R.J."/>
<person name="Sugimoto S."/>
<person name="Bennett A.M."/>
<person name="Kashishian A.S."/>
<person name="Cooper J.A."/>
<person name="Shoelson S.E."/>
<person name="Walsh C.T."/>
<person name="Neel B.G."/>
</authorList>
<dbReference type="PubMed" id="7691811"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION AND ACTIVATION OF PTPN11</scope>
<scope>INTERACTION WITH PTPN11; PIK3R1; PLCG1 AND RASA1</scope>
<scope>MUTAGENESIS OF TYR-1009</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1993" name="Mol. Cell. Biol." volume="13" first="6889" last="6896">
<title>Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor.</title>
<authorList>
<person name="Nishimura R."/>
<person name="Li W."/>
<person name="Kashishian A."/>
<person name="Mondino A."/>
<person name="Zhou M."/>
<person name="Cooper J."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="7692233"/>
<dbReference type="DOI" id="10.1128/MCB.13.11.6889"/>
</citation>
<scope>INTERACTION WITH NCK1 AND PIK3R1</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF NCK1</scope>
<scope>MUTAGENESIS OF TYR-751</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1994" name="Oncogene" volume="9" first="19" last="27">
<title>Shb is a ubiquitously expressed Src homology 2 protein.</title>
<authorList>
<person name="Welsh M."/>
<person name="Mares J."/>
<person name="Karlsson T."/>
<person name="Lavergne C."/>
<person name="Breant B."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="8302579"/>
</citation>
<scope>INTERACTION WITH SHB</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="30942" last="30949">
<title>Grb7 is a downstream signaling component of platelet-derived growth factor alpha- and beta-receptors.</title>
<authorList>
<person name="Yokote K."/>
<person name="Margolis B."/>
<person name="Heldin C.H."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="8940081"/>
<dbReference type="DOI" id="10.1074/jbc.271.48.30942"/>
</citation>
<scope>INTERACTION WITH GRB7</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1997" name="Blood" volume="90" first="4271" last="4277">
<title>Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution.</title>
<authorList>
<person name="Abe A."/>
<person name="Emi N."/>
<person name="Tanimoto M."/>
<person name="Terasaki H."/>
<person name="Marunouchi T."/>
<person name="Saito H."/>
</authorList>
<dbReference type="PubMed" id="9373237"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH TRIP11</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="6217" last="6228">
<title>Grb10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I-, and insulin-mediated mitogenesis.</title>
<authorList>
<person name="Wang J."/>
<person name="Dai H."/>
<person name="Yousaf N."/>
<person name="Moussaif M."/>
<person name="Deng Y."/>
<person name="Boufelliga A."/>
<person name="Swamy O.R."/>
<person name="Leone M.E."/>
<person name="Riedel H."/>
</authorList>
<dbReference type="PubMed" id="10454568"/>
<dbReference type="DOI" id="10.1128/MCB.19.9.6217"/>
</citation>
<scope>INTERACTION WITH GRB10</scope>
<scope>MUTAGENESIS OF TYR-579; TYR-581; TYR-716; TYR-740; TYR-751; TYR-771; TYR-857; TYR-1009 AND TYR-1021</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="759" last="767">
<title>APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis.</title>
<authorList>
<person name="Yokouchi M."/>
<person name="Wakioka T."/>
<person name="Sakamoto H."/>
<person name="Yasukawa H."/>
<person name="Ohtsuka S."/>
<person name="Sasaki A."/>
<person name="Ohtsubo M."/>
<person name="Valius M."/>
<person name="Inoue A."/>
<person name="Komiya S."/>
<person name="Yoshimura A."/>
</authorList>
<dbReference type="PubMed" id="9989826"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202326"/>
</citation>
<scope>INTERACTION WITH SH2B2/APS</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="16219" last="16226">
<title>Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1.</title>
<authorList>
<person name="Kovalenko M."/>
<person name="Denner K."/>
<person name="Sandstrom J."/>
<person name="Persson C."/>
<person name="Gross S."/>
<person name="Jandt E."/>
<person name="Vilella R."/>
<person name="Bohmer F."/>
<person name="Ostman A."/>
</authorList>
<dbReference type="PubMed" id="10821867"/>
<dbReference type="DOI" id="10.1074/jbc.275.21.16219"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-562; TYR-751; TYR-763; TYR-771; TYR-775; TYR-778; TYR-857; TYR-1009 AND TYR-1021</scope>
<scope>DEPHOSPHORYLATION AT TYR-751; TYR-857; TYR-1009 AND TYR-1021 BY PTPRJ</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="3817" last="3830">
<title>Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.</title>
<authorList>
<person name="Arcaro A."/>
<person name="Zvelebil M.J."/>
<person name="Wallasch C."/>
<person name="Ullrich A."/>
<person name="Waterfield M.D."/>
<person name="Domin J."/>
</authorList>
<dbReference type="PubMed" id="10805725"/>
<dbReference type="DOI" id="10.1128/MCB.20.11.3817-3830.2000"/>
</citation>
<scope>INTERACTION WITH PIK3C2B</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="27406" last="27414">
<title>Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor.</title>
<authorList>
<person name="Gilbertson D.G."/>
<person name="Duff M.E."/>
<person name="West J.W."/>
<person name="Kelly J.D."/>
<person name="Sheppard P.O."/>
<person name="Hofstrand P.D."/>
<person name="Gao Z."/>
<person name="Shoemaker K."/>
<person name="Bukowski T.R."/>
<person name="Moore M."/>
<person name="Feldhaus A.L."/>
<person name="Humes J.M."/>
<person name="Palmer T.E."/>
<person name="Hart C.E."/>
</authorList>
<dbReference type="PubMed" id="11297552"/>
<dbReference type="DOI" id="10.1074/jbc.M101056200"/>
</citation>
<scope>FUNCTION AS A RECEPTOR FOR PDGFC</scope>
<scope>INTERACTION WITH PDGFC</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2001" name="Nat. Cell Biol." volume="3" first="512" last="516">
<title>PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor.</title>
<authorList>
<person name="Bergsten E."/>
<person name="Uutela M."/>
<person name="Li X."/>
<person name="Pietras K."/>
<person name="Oestman A."/>
<person name="Heldin C.-H."/>
<person name="Alitalo K."/>
<person name="Eriksson U."/>
</authorList>
<dbReference type="PubMed" id="11331881"/>
<dbReference type="DOI" id="10.1038/35074588"/>
</citation>
<scope>FUNCTION AS A RECEPTOR FOR PDGFD</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2002" name="N. Engl. J. Med." volume="347" first="481" last="487">
<title>Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.</title>
<authorList>
<person name="Apperley J.F."/>
<person name="Gardembas M."/>
<person name="Melo J.V."/>
<person name="Russell-Jones R."/>
<person name="Bain B.J."/>
<person name="Baxter E.J."/>
<person name="Chase A."/>
<person name="Chessells J.M."/>
<person name="Colombat M."/>
<person name="Dearden C.E."/>
<person name="Dimitrijevic S."/>
<person name="Mahon F.-X."/>
<person name="Marin D."/>
<person name="Nikolova Z."/>
<person name="Olavarria E."/>
<person name="Silberman S."/>
<person name="Schultheis B."/>
<person name="Cross N.C.P."/>
<person name="Goldman J.M."/>
</authorList>
<dbReference type="PubMed" id="12181402"/>
<dbReference type="DOI" id="10.1056/NEJMoa020150"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH ETV6</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2003" name="Blood" volume="102" first="4187" last="4190">
<title>Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib.</title>
<authorList>
<person name="Wilkinson K."/>
<person name="Velloso E.R.P."/>
<person name="Lopes L.F."/>
<person name="Lee C."/>
<person name="Aster J.C."/>
<person name="Shipp M.A."/>
<person name="Aguiar R.C.T."/>
</authorList>
<dbReference type="PubMed" id="12907457"/>
<dbReference type="DOI" id="10.1182/blood-2003-04-1150"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH PDE4DIP</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2004" name="Cancer Res." volume="64" first="2649" last="2651">
<title>HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2).</title>
<authorList>
<person name="Morerio C."/>
<person name="Acquila M."/>
<person name="Rosanda C."/>
<person name="Rapella A."/>
<person name="Dufour C."/>
<person name="Locatelli F."/>
<person name="Maserati E."/>
<person name="Pasquali F."/>
<person name="Panarello C."/>
</authorList>
<dbReference type="PubMed" id="15087372"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-03-4026"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH SPECC1</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2004" name="Cancer Res." volume="64" first="7216" last="7219">
<title>p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder.</title>
<authorList>
<person name="Grand F.H."/>
<person name="Burgstaller S."/>
<person name="Kuhr T."/>
<person name="Baxter E.J."/>
<person name="Webersinke G."/>
<person name="Thaler J."/>
<person name="Chase A.J."/>
<person name="Cross N.C."/>
</authorList>
<dbReference type="PubMed" id="15492236"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-04-2005"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH TP53BP1</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="2190" last="2201">
<title>Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase.</title>
<authorList>
<person name="Persson C."/>
<person name="Saevenhed C."/>
<person name="Bourdeau A."/>
<person name="Tremblay M.L."/>
<person name="Markova B."/>
<person name="Boehmer F.D."/>
<person name="Haj F.G."/>
<person name="Neel B.G."/>
<person name="Elson A."/>
<person name="Heldin C.H."/>
<person name="Roennstrand L."/>
<person name="Ostman A."/>
<person name="Hellberg C."/>
</authorList>
<dbReference type="PubMed" id="14966296"/>
<dbReference type="DOI" id="10.1128/MCB.24.5.2190-2201.2004"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-579; TYR-751; TYR-771 AND TYR-1021</scope>
<scope>DEPHOSPHORYLATION AT TYR-579 AND TYR-1021 BY PTPN2</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2005" name="Nature" volume="435" first="347" last="353">
<title>Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II.</title>
<authorList>
<person name="Choi M.H."/>
<person name="Lee I.K."/>
<person name="Kim G.W."/>
<person name="Kim B.U."/>
<person name="Han Y.H."/>
<person name="Yu D.Y."/>
<person name="Park H.S."/>
<person name="Kim K.Y."/>
<person name="Lee J.S."/>
<person name="Choi C."/>
<person name="Bae Y.S."/>
<person name="Lee B.I."/>
<person name="Rhee S.G."/>
<person name="Kang S.W."/>
</authorList>
<dbReference type="PubMed" id="15902258"/>
<dbReference type="DOI" id="10.1038/nature03587"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-579; TYR-581; TYR-716; TYR-740; TYR-771; TYR-857; TYR-1009 AND TYR-1021</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="29336" last="29347">
<title>Binding of Cbl to a phospholipase Cgamma1-docking site on platelet-derived growth factor receptor beta provides a dual mechanism of negative regulation.</title>
<authorList>
<person name="Reddi A.L."/>
<person name="Ying G."/>
<person name="Duan L."/>
<person name="Chen G."/>
<person name="Dimri M."/>
<person name="Douillard P."/>
<person name="Druker B.J."/>
<person name="Naramura M."/>
<person name="Band V."/>
<person name="Band H."/>
</authorList>
<dbReference type="PubMed" id="17620338"/>
<dbReference type="DOI" id="10.1074/jbc.M701797200"/>
</citation>
<scope>INTERACTION WITH CBL</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-1021</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2010" name="Cancer Res." volume="70" first="9631" last="9640">
<title>A novel signaling axis of matriptase/PDGF-D/ss-PDGFR in human prostate cancer.</title>
<authorList>
<person name="Ustach C.V."/>
<person name="Huang W."/>
<person name="Conley-LaComb M.K."/>
<person name="Lin C.Y."/>
<person name="Che M."/>
<person name="Abrams J."/>
<person name="Kim H.R."/>
</authorList>
<dbReference type="PubMed" id="21098708"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-0511"/>
</citation>
<scope>FUNCTION AS PDGFD RECEPTOR</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2010" name="Cell. Signal." volume="22" first="1363" last="1368">
<title>Mutation of tyrosine residue 857 in the PDGF beta-receptor affects cell proliferation but not migration.</title>
<authorList>
<person name="Wardega P."/>
<person name="Heldin C.H."/>
<person name="Lennartsson J."/>
</authorList>
<dbReference type="PubMed" id="20494825"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2010.05.004"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CBL; STAM; PDCD6IP/ALIX; PLCG1 AND PTPN11</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-634 AND TYR-857</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="25024" last="25032">
<title>Stimulation of platelet-derived growth factor receptor beta (PDGFRbeta) activates ADAM17 and promotes metalloproteinase-dependent cross-talk between the PDGFRbeta and epidermal growth factor receptor (EGFR) signaling pathways.</title>
<authorList>
<person name="Mendelson K."/>
<person name="Swendeman S."/>
<person name="Saftig P."/>
<person name="Blobel C.P."/>
</authorList>
<dbReference type="PubMed" id="20529858"/>
<dbReference type="DOI" id="10.1074/jbc.M110.102566"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="Br. J. Nutr." volume="107" first="24" last="35">
<title>Glyceollins inhibit platelet-derived growth factor-mediated human arterial smooth muscle cell proliferation and migration.</title>
<authorList>
<person name="Kim H.J."/>
<person name="Cha B.Y."/>
<person name="Choi B."/>
<person name="Lim J.S."/>
<person name="Woo J.T."/>
<person name="Kim J.S."/>
</authorList>
<dbReference type="PubMed" id="21733313"/>
<dbReference type="DOI" id="10.1017/S0007114511002571"/>
</citation>
<scope>FUNCTION IN SMOOTH MUSCLE CELL PROLIFERATION AND MIGRATION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="15337" last="15343">
<title>Direct interaction between Shc and the platelet-derived growth factor beta-receptor.</title>
<authorList>
<person name="Yokote K."/>
<person name="Mori S."/>
<person name="Hansen K."/>
<person name="McGlade J."/>
<person name="Pawson T."/>
<person name="Heldin C.H."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="8195171"/>
</citation>
<scope>INTERACTION WITH SHC1 AND GRB2</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF SHC1</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2011" name="J. Am. Coll. Cardiol." volume="57" first="2527" last="2538">
<title>Disruption of platelet-derived growth factor-dependent phosphatidylinositol 3-kinase and phospholipase Cgamma 1 activity abolishes vascular smooth muscle cell proliferation and migration and attenuates neointima formation in vivo.</title>
<authorList>
<person name="Caglayan E."/>
<person name="Vantler M."/>
<person name="Leppanen O."/>
<person name="Gerhardt F."/>
<person name="Mustafov L."/>
<person name="Ten Freyhaus H."/>
<person name="Kappert K."/>
<person name="Odenthal M."/>
<person name="Zimmermann W.H."/>
<person name="Tallquist M.D."/>
<person name="Rosenkranz S."/>
</authorList>
<dbReference type="PubMed" id="21679854"/>
<dbReference type="DOI" id="10.1016/j.jacc.2011.02.037"/>
</citation>
<scope>FUNCTION IN SMOOTH MUSCLE CELL MIGRATION AND NEOINTIMA FORMATION AFTER BLOOD VESSEL INJURY</scope>
<scope>MUTAGENESIS OF TYR-740; TYR-751 AND TYR-1021</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2015" name="Am. J. Hum. Genet." volume="97" first="465" last="474">
<title>A point mutation in PDGFRB causes autosomal-dominant Penttinen syndrome.</title>
<authorList>
<person name="Johnston J.J."/>
<person name="Sanchez-Contreras M.Y."/>
<person name="Keppler-Noreuil K.M."/>
<person name="Sapp J."/>
<person name="Crenshaw M."/>
<person name="Finch N.A."/>
<person name="Cormier-Daire V."/>
<person name="Rademakers R."/>
<person name="Sybert V.P."/>
<person name="Biesecker L.G."/>
</authorList>
<dbReference type="PubMed" id="26279204"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2015.07.009"/>
</citation>
<scope>INVOLVEMENT IN PENTT</scope>
<scope>VARIANT PENTT ALA-665</scope>
<scope>CHARACTERIZATION OF VARIANT PENTT ALA-665</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2015" name="J. Pediatr." volume="166" first="483" last="486">
<title>Novel overgrowth syndrome phenotype due to recurrent de novo PDGFRB mutation.</title>
<authorList>
<person name="Takenouchi T."/>
<person name="Yamaguchi Y."/>
<person name="Tanikawa A."/>
<person name="Kosaki R."/>
<person name="Okano H."/>
<person name="Kosaki K."/>
</authorList>
<dbReference type="PubMed" id="25454926"/>
<dbReference type="DOI" id="10.1016/j.jpeds.2014.10.015"/>
</citation>
<scope>INVOLVEMENT IN KOGS</scope>
<scope>VARIANT KOGS ARG-584</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0143407" last="E0143407">
<title>Functional characterization of germline mutations in PDGFB and PDGFRB in primary familial brain calcification.</title>
<authorList>
<person name="Vanlandewijck M."/>
<person name="Lebouvier T."/>
<person name="Andaloussi Maee M."/>
<person name="Nahar K."/>
<person name="Hornemann S."/>
<person name="Kenkel D."/>
<person name="Cunha S.I."/>
<person name="Lennartsson J."/>
<person name="Boss A."/>
<person name="Heldin C.H."/>
<person name="Keller A."/>
<person name="Betsholtz C."/>
</authorList>
<dbReference type="PubMed" id="26599395"/>
<dbReference type="DOI" id="10.1371/journal.pone.0143407"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS IBGC4 PRO-658; TRP-987 AND VAL-1071</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1998" name="Biochim. Biophys. Acta" volume="1378" first="F79" last="113">
<title>Signal transduction via platelet-derived growth factor receptors.</title>
<authorList>
<person name="Heldin C.H."/>
<person name="Ostman A."/>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="9739761"/>
<dbReference type="DOI" id="10.1016/S0304-419X(98)00015-8"/>
</citation>
<scope>REVIEW ON SIGNALING AND AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2004" name="Cytokine Growth Factor Rev." volume="15" first="275" last="286">
<title>PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma.</title>
<authorList>
<person name="Ostman A."/>
</authorList>
<dbReference type="PubMed" id="15207817"/>
<dbReference type="DOI" id="10.1016/j.cytogfr.2004.03.002"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2007" name="Adv. Cancer Res." volume="97" first="247" last="274">
<title>PDGF receptors as targets in tumor treatment.</title>
<authorList>
<person name="Ostman A."/>
<person name="Heldin C.H."/>
</authorList>
<dbReference type="PubMed" id="17419949"/>
<dbReference type="DOI" id="10.1016/S0065-230X(06)97011-0"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2008" name="Genes Dev." volume="22" first="1276" last="1312">
<title>Role of platelet-derived growth factors in physiology and medicine.</title>
<authorList>
<person name="Andrae J."/>
<person name="Gallini R."/>
<person name="Betsholtz C."/>
</authorList>
<dbReference type="PubMed" id="18483217"/>
<dbReference type="DOI" id="10.1101/gad.1653708"/>
</citation>
<scope>REVIEW ON FUNCTION; LIGANDS; ROLE IN DEVELOPMENT AND DISEASE AND ACTIVATION OF SIGNALING PATHWAYS</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2001" name="Acta Crystallogr. D" volume="57" first="1397" last="1404">
<title>NMR trial models: experiences with the colicin immunity protein Im7 and the p85alpha C-terminal SH2-peptide complex.</title>
<authorList>
<person name="Pauptit R.A."/>
<person name="Dennis C.A."/>
<person name="Derbyshire D.J."/>
<person name="Breeze A.L."/>
<person name="Weston S.A."/>
<person name="Rowsell S."/>
<person name="Murshudov G.N."/>
</authorList>
<dbReference type="PubMed" id="11567151"/>
<dbReference type="DOI" id="10.1107/S0907444901012434"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS) OF 751-755 IN COMPLEX WITH PIK3R1</scope>
<scope>COMPARISON WITH NMR ANALYSIS</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="18973" last="18978">
<title>Structural determinants of the Na+/H+ exchanger regulatory factor interaction with the beta 2 adrenergic and platelet-derived growth factor receptors.</title>
<authorList>
<person name="Karthikeyan S."/>
<person name="Leung T."/>
<person name="Ladias J.A.A."/>
</authorList>
<dbReference type="PubMed" id="11882663"/>
<dbReference type="DOI" id="10.1074/jbc.M201507200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1102-1106 IN COMPLEX WITH SLC9A3R1</scope>
<scope>INTERACTION WITH SLC9A3R1</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="11307" last="11312">
<title>Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex.</title>
<authorList>
<person name="Shim A.H."/>
<person name="Liu H."/>
<person name="Focia P.J."/>
<person name="Chen X."/>
<person name="Lin P.C."/>
<person name="He X."/>
</authorList>
<dbReference type="PubMed" id="20534510"/>
<dbReference type="DOI" id="10.1073/pnas.1000806107"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 33-314 IN COMPLEX WITH PDGFB</scope>
<scope>SUBUNIT</scope>
<scope>GLYCOSYLATION AT ASN-45; ASN-89; ASN-103; ASN-215; ASN-230; ASN-292 AND ASN-307</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] PHE-29; LYS-282; LYS-485; HIS-589; TYR-718 AND ILE-882</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2013" name="Am. J. Hum. Genet." volume="92" first="1001" last="1007">
<title>Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis.</title>
<authorList>
<person name="Martignetti J.A."/>
<person name="Tian L."/>
<person name="Li D."/>
<person name="Ramirez M.C."/>
<person name="Camacho-Vanegas O."/>
<person name="Camacho S.C."/>
<person name="Guo Y."/>
<person name="Zand D.J."/>
<person name="Bernstein A.M."/>
<person name="Masur S.K."/>
<person name="Kim C.E."/>
<person name="Otieno F.G."/>
<person name="Hou C."/>
<person name="Abdel-Magid N."/>
<person name="Tweddale B."/>
<person name="Metry D."/>
<person name="Fournet J.C."/>
<person name="Papp E."/>
<person name="McPherson E.W."/>
<person name="Zabel C."/>
<person name="Vaksmann G."/>
<person name="Morisot C."/>
<person name="Keating B."/>
<person name="Sleiman P.M."/>
<person name="Cleveland J.A."/>
<person name="Everman D.B."/>
<person name="Zackai E."/>
<person name="Hakonarson H."/>
</authorList>
<dbReference type="PubMed" id="23731542"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2013.04.024"/>
</citation>
<scope>VARIANT IMF1 THR-660</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2013" name="Am. J. Hum. Genet." volume="92" first="996" last="1000">
<title>A recurrent PDGFRB mutation causes familial infantile myofibromatosis.</title>
<authorList>
<person name="Cheung Y.H."/>
<person name="Gayden T."/>
<person name="Campeau P.M."/>
<person name="Leduc C.A."/>
<person name="Russo D."/>
<person name="Nguyen V.H."/>
<person name="Guo J."/>
<person name="Qi M."/>
<person name="Guan Y."/>
<person name="Albrecht S."/>
<person name="Moroz B."/>
<person name="Eldin K.W."/>
<person name="Lu J.T."/>
<person name="Schwartzentruber J."/>
<person name="Malkin D."/>
<person name="Berghuis A.M."/>
<person name="Emil S."/>
<person name="Gibbs R.A."/>
<person name="Burk D.L."/>
<person name="Vanstone M."/>
<person name="Lee B.H."/>
<person name="Orchard D."/>
<person name="Boycott K.M."/>
<person name="Chung W.K."/>
<person name="Jabado N."/>
</authorList>
<dbReference type="PubMed" id="23731537"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2013.04.026"/>
</citation>
<scope>VARIANT IMF1 CYS-561</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2013" name="Brain" volume="136" first="3395" last="3407">
<title>Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification.</title>
<authorList>
<consortium name="French IBGC Study Group"/>
<person name="Nicolas G."/>
<person name="Pottier C."/>
<person name="Charbonnier C."/>
<person name="Guyant-Marechal L."/>
<person name="Le Ber I."/>
<person name="Pariente J."/>
<person name="Labauge P."/>
<person name="Ayrignac X."/>
<person name="Defebvre L."/>
<person name="Maltete D."/>
<person name="Martinaud O."/>
<person name="Lefaucheur R."/>
<person name="Guillin O."/>
<person name="Wallon D."/>
<person name="Chaumette B."/>
<person name="Rondepierre P."/>
<person name="Derache N."/>
<person name="Fromager G."/>
<person name="Schaeffer S."/>
<person name="Krystkowiak P."/>
<person name="Verny C."/>
<person name="Jurici S."/>
<person name="Sauvee M."/>
<person name="Verin M."/>
<person name="Lebouvier T."/>
<person name="Rouaud O."/>
<person name="Thauvin-Robinet C."/>
<person name="Rousseau S."/>
<person name="Rovelet-Lecrux A."/>
<person name="Frebourg T."/>
<person name="Campion D."/>
<person name="Hannequin D."/>
</authorList>
<dbReference type="PubMed" id="24065723"/>
<dbReference type="DOI" id="10.1093/brain/awt255"/>
</citation>
<scope>VARIANTS IBGC4 PRO-658; TRP-987 AND VAL-1071</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2013" name="Neurology" volume="80" first="181" last="187">
<title>Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification.</title>
<authorList>
<person name="Nicolas G."/>
<person name="Pottier C."/>
<person name="Maltete D."/>
<person name="Coutant S."/>
<person name="Rovelet-Lecrux A."/>
<person name="Legallic S."/>
<person name="Rousseau S."/>
<person name="Vaschalde Y."/>
<person name="Guyant-Marechal L."/>
<person name="Augustin J."/>
<person name="Martinaud O."/>
<person name="Defebvre L."/>
<person name="Krystkowiak P."/>
<person name="Pariente J."/>
<person name="Clanet M."/>
<person name="Labauge P."/>
<person name="Ayrignac X."/>
<person name="Lefaucheur R."/>
<person name="Le Ber I."/>
<person name="Frebourg T."/>
<person name="Hannequin D."/>
<person name="Campion D."/>
</authorList>
<dbReference type="PubMed" id="23255827"/>
<dbReference type="DOI" id="10.1212/WNL.0b013e31827ccf34"/>
</citation>
<scope>VARIANTS IBGC4 PRO-658 AND TRP-987</scope>
</reference>
<comment type="function">
<text evidence="11 12 18 20 27 28 31 32 33 35 36 37 45 47 48 49 51 52 53 54">Tyrosine-protein kinase that acts as cell-surface receptor for homodimeric PDGFB and PDGFD and for heterodimers formed by PDGFA and PDGFB, and plays an essential role in the regulation of embryonic development, cell proliferation, survival, differentiation, chemotaxis and migration. Plays an essential role in blood vessel development by promoting proliferation, migration and recruitment of pericytes and smooth muscle cells to endothelial cells. Plays a role in the migration of vascular smooth muscle cells and the formation of neointima at vascular injury sites. Required for normal development of the cardiovascular system. Required for normal recruitment of pericytes (mesangial cells) in the kidney glomerulus, and for normal formation of a branched network of capillaries in kidney glomeruli. Promotes rearrangement of the actin cytoskeleton and the formation of membrane ruffles. Binding of its cognate ligands - homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFD -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PLCG1, PIK3R1, PTPN11, RASA1/GAP, CBL, SHC1 and NCK1. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, leads to the activation of the AKT1 signaling pathway. Phosphorylation of SHC1, or of the C-terminus of PTPN11, creates a binding site for GRB2, resulting in the activation of HRAS, RAF1 and down-stream MAP kinases, including MAPK1/ERK2 and/or MAPK3/ERK1. Promotes phosphorylation and activation of SRC family kinases. Promotes phosphorylation of PDCD6IP/ALIX and STAM. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor.</text>
</comment>
<comment type="catalytic activity">
<text evidence="7 31 32 51">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="25">Present in an inactive conformation in the absence of bound ligand. Binding of PDGFB and/or PDGFD leads to dimerization and activation by autophosphorylation on tyrosine residues. Inhibited by imatinib.</text>
</comment>
<comment type="subunit">
<text evidence="8 9 11 13 14 18 19 20 28 30 34 48 49 50 52 53 54 55 56 58">Interacts with homodimeric PDGFB and PDGFD, and with heterodimers formed by PDGFA and PDGFB. May also interact with homodimeric PDGFC. Monomer in the absence of bound ligand. Interaction with homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFD, leads to receptor dimerization, where both PDGFRA homodimers and heterodimers with PDGFRB are observed. Interacts with SH2B2/APS. Interacts directly (tyrosine phosphorylated) with SHB. Interacts (tyrosine phosphorylated) with PIK3R1 and RASA1. Interacts (tyrosine phosphorylated) with CBL. Interacts (tyrosine phosphorylated) with SRC and SRC family kinases. Interacts (tyrosine phosphorylated) with PIK3C2B, maybe indirectly. Interacts (tyrosine phosphorylated) with SHC1, GRB7, GRB10 and NCK1. Interaction with GRB2 is mediated by SHC1. Interacts (via C-terminus) with SLC9A3R1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-7015490">
<id>P0CK45</id>
<label>E5</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-515315">
<id>P06241</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-970191">
<id>Q14451</id>
<label>GRB7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-740929">
<id>Q53G59</id>
<label>KLHL12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-1554925">
<id>P01127</id>
<label>PDGFB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-520244">
<id>P23727</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>19</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-8013886">
<id>P08487</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-696162">
<id>P60484</id>
<label>PTEN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-968788">
<id>P18031</id>
<label>PTPN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-297779">
<id>Q06124</id>
<label>PTPN11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-2266035">
<id>Q05209</id>
<label>PTPN12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-2264500">
<id>Q12913</id>
<label>PTPRJ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-365996">
<id>P04049</id>
<label>RAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-1026476">
<id>P20936</id>
<label>RASA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-726214">
<id>Q13239</id>
<label>SLA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-349787">
<id>O14745</id>
<label>SLC9A3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-742327">
<id>Q15654</id>
<label>TRIP6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641237"/>
<interactant intactId="EBI-8636140">
<id>P25020</id>
<label>V-SRC</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasmic vesicle</location>
</subcellularLocation>
<subcellularLocation>
<location>Lysosome lumen</location>
</subcellularLocation>
<text>After ligand binding, the autophosphorylated receptor is ubiquitinated and internalized, leading to its degradation.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P09619-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P09619-2</id>
<name>2</name>
<sequence type="described" ref="VSP_056008 VSP_056009"/>
</isoform>
</comment>
<comment type="PTM">
<text evidence="10 18 20 21 26 28 44 51">Autophosphorylated on tyrosine residues upon ligand binding. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Phosphorylation at Tyr-579, and to a lesser degree, at Tyr-581, is important for interaction with SRC family kinases. Phosphorylation at Tyr-740 and Tyr-751 is important for interaction with PIK3R1. Phosphorylation at Tyr-751 is important for interaction with NCK1. Phosphorylation at Tyr-771 and Tyr-857 is important for interaction with RASA1/GAP. Phosphorylation at Tyr-857 is important for efficient phosphorylation of PLCG1 and PTPN11, resulting in increased phosphorylation of AKT1, MAPK1/ERK2 and/or MAPK3/ERK1, PDCD6IP/ALIX and STAM, and in increased cell proliferation. Phosphorylation at Tyr-1009 is important for interaction with PTPN11. Phosphorylation at Tyr-1009 and Tyr-1021 is important for interaction with PLCG1. Phosphorylation at Tyr-1021 is important for interaction with CBL; PLCG1 and CBL compete for the same binding site. Dephosphorylated by PTPRJ at Tyr-751, Tyr-857, Tyr-1009 and Tyr-1021. Dephosphorylated by PTPN2 at Tyr-579 and Tyr-1021.</text>
</comment>
<comment type="PTM">
<text evidence="34 49">N-glycosylated.</text>
</comment>
<comment type="PTM">
<text evidence="17 30">Ubiquitinated. After autophosphorylation, the receptor is polyubiquitinated, leading to its degradation.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving PDGFRB is found in a form of chronic myelomonocytic leukemia (CMML). Translocation t(5;12)(q33;p13) with EVT6/TEL. It is characterized by abnormal clonal myeloid proliferation and by progression to acute myelogenous leukemia (AML).</text>
</comment>
<comment type="disease">
<disease id="DI-02609">
<name>Myeloproliferative disorder chronic with eosinophilia</name>
<acronym>MPE</acronym>
<description>A hematologic disorder characterized by malignant eosinophils proliferation.</description>
<dbReference type="MIM" id="131440"/>
</disease>
<text evidence="15 16 25 38">The gene represented in this entry may be involved in disease pathogenesis. Chromosomal aberrations involving PDGFRB have been found in many instances of chronic myeloproliferative disorder with eosinophilia. Translocation t(5;12) with ETV6 on chromosome 12 creating an PDGFRB-ETV6 fusion protein (PubMed:12181402). Translocation t(5;15)(q33;q22) with TP53BP1 creating a PDGFRB-TP53BP1 fusion protein (PubMed:15492236). Translocation t(1;5)(q23;q33) that forms a PDE4DIP-PDGFRB fusion protein (PubMed:12907457). Translocation t(5;6)(q33-34;q23) with CEP85L that fuses the 5'-end of CEP85L (isoform 4) to the 3'-end of PDGFRB (PubMed:21938754).</text>
</comment>
<comment type="disease">
<disease id="DI-01171">
<name>Leukemia, acute myelogenous</name>
<acronym>AML</acronym>
<description>A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes.</description>
<dbReference type="MIM" id="601626"/>
</disease>
<text evidence="57">The gene represented in this entry may be involved in disease pathogenesis. A chromosomal aberration involving PDGFRB has been found in a patient with AML. Translocation t(5;14)(q33;q32) with TRIP11 (PubMed:9373237).</text>
</comment>
<comment type="disease">
<disease id="DI-01851">
<name>Leukemia, juvenile myelomonocytic</name>
<acronym>JMML</acronym>
<description>An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages.</description>
<dbReference type="MIM" id="607785"/>
</disease>
<text evidence="22">The gene represented in this entry may be involved in disease pathogenesis. A chromosomal aberration involving PDGFRB has been found in a patient with JMML. Translocation t(5;17)(q33;p11.2) with SPECC1 (PubMed:15087372).</text>
</comment>
<comment type="disease" evidence="39 42 47">
<disease id="DI-03665">
<name>Basal ganglia calcification, idiopathic, 4</name>
<acronym>IBGC4</acronym>
<description>A form of basal ganglia calcification, an autosomal dominant condition characterized by symmetric calcification in the basal ganglia and other brain regions. Affected individuals can either be asymptomatic or show a wide spectrum of neuropsychiatric symptoms, including parkinsonism, dystonia, tremor, ataxia, dementia, psychosis, seizures, and chronic headache. Serum levels of calcium, phosphate, alkaline phosphatase and parathyroid hormone are normal. The neuropathological hallmark of the disease is vascular and pericapillary calcification, mainly of calcium phosphate, in the affected brain areas.</description>
<dbReference type="MIM" id="615007"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="40 41">
<disease id="DI-03815">
<name>Myofibromatosis, infantile 1</name>
<acronym>IMF1</acronym>
<description>A rare mesenchymal disorder characterized by the development of benign tumors in the skin, striated muscles, bones, and, more rarely, visceral organs. Subcutaneous or soft tissue nodules commonly involve the skin of the head, neck, and trunk. Skeletal and muscular lesions occur in about half of the patients. Lesions may be solitary or multicentric, and they may be present at birth or become apparent in early infancy or occasionally in adult life. Visceral lesions are associated with high morbidity and mortality.</description>
<dbReference type="MIM" id="228550"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="43">
<disease id="DI-04560">
<name>Kosaki overgrowth syndrome</name>
<acronym>KOGS</acronym>
<description>A syndrome characterized by somatic overgrowth, distinctive facial features, hyperelastic and fragile skin, and progressive neurologic deterioration with white matter lesions on brain imaging.</description>
<dbReference type="MIM" id="616592"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="46">
<disease id="DI-04566">
<name>Premature aging syndrome, Penttinen type</name>
<acronym>PENTT</acronym>
<description>A syndrome characterized by a prematurely aged appearance with lipoatrophy, epidermal and dermal atrophy along with hypertrophic lesions that resemble scars, thin hair, proptosis, underdeveloped cheekbones, and marked acro-osteolysis.</description>
<dbReference type="MIM" id="601812"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PDGFRBID21ch5q32.html"/>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="J03278">
<property type="protein sequence ID" value="AAA60049.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M21616">
<property type="protein sequence ID" value="AAA36427.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU826595">
<property type="protein sequence ID" value="ACF47631.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC005895">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC011382">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC032224">
<property type="protein sequence ID" value="AAH32224.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U33172">
<property type="protein sequence ID" value="AAC51675.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4303.1">
<molecule id="P09619-1"/>
</dbReference>
<dbReference type="PIR" id="A28206">
<property type="entry name" value="PFHUGB"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002600.1">
<molecule id="P09619-1"/>
<property type="nucleotide sequence ID" value="NM_002609.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011535960.1">
<molecule id="P09619-1"/>
<property type="nucleotide sequence ID" value="XM_011537658.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011535961.1">
<molecule id="P09619-1"/>
<property type="nucleotide sequence ID" value="XM_011537659.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.509067"/>
<dbReference type="PDB" id="1GQ5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1102-1106"/>
</dbReference>
<dbReference type="PDB" id="1H9O">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="B=751-755"/>
</dbReference>
<dbReference type="PDB" id="1LWP">
<property type="method" value="Model"/>
<property type="chains" value="A=600-962"/>
</dbReference>
<dbReference type="PDB" id="1SHA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="B=751-755"/>
</dbReference>
<dbReference type="PDB" id="2L6W">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=526-563"/>
</dbReference>
<dbReference type="PDB" id="2PLD">
<property type="method" value="NMR"/>
<property type="chains" value="B=1018-1029"/>
</dbReference>
<dbReference type="PDB" id="2PLE">
<property type="method" value="NMR"/>
<property type="chains" value="B=1018-1029"/>
</dbReference>
<dbReference type="PDB" id="3MJG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="X/Y=33-314"/>
</dbReference>
<dbReference type="PDBsum" id="1GQ5"/>
<dbReference type="PDBsum" id="1H9O"/>
<dbReference type="PDBsum" id="1LWP"/>
<dbReference type="PDBsum" id="1SHA"/>
<dbReference type="PDBsum" id="2L6W"/>
<dbReference type="PDBsum" id="2PLD"/>
<dbReference type="PDBsum" id="2PLE"/>
<dbReference type="PDBsum" id="3MJG"/>
<dbReference type="ProteinModelPortal" id="P09619"/>
<dbReference type="SMR" id="P09619"/>
<dbReference type="BioGrid" id="111185">
<property type="interactions" value="73"/>
</dbReference>
<dbReference type="DIP" id="DIP-558N"/>
<dbReference type="IntAct" id="P09619">
<property type="interactions" value="81"/>
</dbReference>
<dbReference type="MINT" id="MINT-148093"/>
<dbReference type="STRING" id="9606.ENSP00000261799"/>
<dbReference type="BindingDB" id="P09619"/>
<dbReference type="ChEMBL" id="CHEMBL1913"/>
<dbReference type="DrugBank" id="DB00102">
<property type="generic name" value="Becaplermin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01254">
<property type="generic name" value="Dasatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00619">
<property type="generic name" value="Imatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB06589">
<property type="generic name" value="Pazopanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00398">
<property type="generic name" value="Sorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01268">
<property type="generic name" value="Sunitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05146">
<property type="generic name" value="XL820"/>
</dbReference>
<dbReference type="DrugBank" id="DB05014">
<property type="generic name" value="XL999"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1804"/>
<dbReference type="iPTMnet" id="P09619"/>
<dbReference type="PhosphoSitePlus" id="P09619"/>
<dbReference type="BioMuta" id="PDGFRB"/>
<dbReference type="DMDM" id="129890"/>
<dbReference type="EPD" id="P09619"/>
<dbReference type="MaxQB" id="P09619"/>
<dbReference type="PaxDb" id="P09619"/>
<dbReference type="PeptideAtlas" id="P09619"/>
<dbReference type="PRIDE" id="P09619"/>
<dbReference type="DNASU" id="5159"/>
<dbReference type="Ensembl" id="ENST00000261799">
<molecule id="P09619-1"/>
<property type="protein sequence ID" value="ENSP00000261799"/>
<property type="gene ID" value="ENSG00000113721"/>
</dbReference>
<dbReference type="GeneID" id="5159"/>
<dbReference type="KEGG" id="hsa:5159"/>
<dbReference type="UCSC" id="uc003lro.4">
<molecule id="P09619-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5159"/>
<dbReference type="DisGeNET" id="5159"/>
<dbReference type="GeneCards" id="PDGFRB"/>
<dbReference type="GeneReviews" id="PDGFRB"/>
<dbReference type="HGNC" id="HGNC:8804">
<property type="gene designation" value="PDGFRB"/>
</dbReference>
<dbReference type="HPA" id="CAB003842"/>
<dbReference type="HPA" id="CAB018144"/>
<dbReference type="HPA" id="HPA028499"/>
<dbReference type="MalaCards" id="PDGFRB"/>
<dbReference type="MIM" id="131440">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="173410">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="228550">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601626">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601812">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="607785">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="615007">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616592">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P09619"/>
<dbReference type="OpenTargets" id="ENSG00000113721"/>
<dbReference type="Orphanet" id="1980">
<property type="disease" value="Bilateral striopallidodentate calcinosis"/>
</dbReference>
<dbReference type="Orphanet" id="98823">
<property type="disease" value="Chronic myelomonocytic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="2591">
<property type="disease" value="Infantile myofibromatosis"/>
</dbReference>
<dbReference type="Orphanet" id="168950">
<property type="disease" value="Myeloid neoplasm associated with PDGFRB rearrangement"/>
</dbReference>
<dbReference type="Orphanet" id="314950">
<property type="disease" value="Primary hypereosinophilic syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="86830">
<property type="disease" value="Unclassified chronic myeloproliferative disease"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33148"/>
<dbReference type="eggNOG" id="KOG0200">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118923"/>
<dbReference type="HOGENOM" id="HOG000112009"/>
<dbReference type="HOVERGEN" id="HBG004335"/>
<dbReference type="InParanoid" id="P09619"/>
<dbReference type="KO" id="K05089"/>
<dbReference type="OMA" id="APYDNYV"/>
<dbReference type="OrthoDB" id="EOG091G01TL"/>
<dbReference type="PhylomeDB" id="P09619"/>
<dbReference type="TreeFam" id="TF325768"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-186763">
<property type="pathway name" value="Downstream signal transduction"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-186797">
<property type="pathway name" value="Signaling by PDGF"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P09619"/>
<dbReference type="SIGNOR" id="P09619"/>
<dbReference type="ChiTaRS" id="PDGFRB">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P09619"/>
<dbReference type="GeneWiki" id="PDGFRB"/>
<dbReference type="GenomeRNAi" id="5159"/>
<dbReference type="PRO" id="PR:P09619"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000113721"/>
<dbReference type="CleanEx" id="HS_PDGFRB"/>
<dbReference type="ExpressionAtlas" id="P09619">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P09619">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031410">
<property type="term" value="C:cytoplasmic vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0031226">
<property type="term" value="C:intrinsic component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043202">
<property type="term" value="C:lysosomal lumen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043548">
<property type="term" value="F:phosphatidylinositol 3-kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004992">
<property type="term" value="F:platelet activating factor receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005019">
<property type="term" value="F:platelet-derived growth factor beta-receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048407">
<property type="term" value="F:platelet-derived growth factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005161">
<property type="term" value="F:platelet-derived growth factor receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005017">
<property type="term" value="F:platelet-derived growth factor-activated receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038085">
<property type="term" value="F:vascular endothelial growth factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007568">
<property type="term" value="P:aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035909">
<property type="term" value="P:aorta morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0055003">
<property type="term" value="P:cardiac myofibril assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060326">
<property type="term" value="P:cell chemotaxis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060981">
<property type="term" value="P:cell migration involved in coronary angiogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035441">
<property type="term" value="P:cell migration involved in vasculogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006024">
<property type="term" value="P:glycosaminoglycan biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048839">
<property type="term" value="P:inner ear development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060437">
<property type="term" value="P:lung growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008584">
<property type="term" value="P:male gonad development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0072278">
<property type="term" value="P:metanephric comma-shaped body morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0072277">
<property type="term" value="P:metanephric glomerular capillary formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072262">
<property type="term" value="P:metanephric glomerular mesangial cell proliferation involved in metanephros development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035789">
<property type="term" value="P:metanephric mesenchymal cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0072075">
<property type="term" value="P:metanephric mesenchyme development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0072284">
<property type="term" value="P:metanephric S-shaped body morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000587">
<property type="term" value="P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046488">
<property type="term" value="P:phosphatidylinositol metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048015">
<property type="term" value="P:phosphatidylinositol-mediated signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048008">
<property type="term" value="P:platelet-derived growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035791">
<property type="term" value="P:platelet-derived growth factor receptor-beta signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090280">
<property type="term" value="P:positive regulation of calcium ion import"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038091">
<property type="term" value="P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050921">
<property type="term" value="P:positive regulation of chemotaxis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032967">
<property type="term" value="P:positive regulation of collagen biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000573">
<property type="term" value="P:positive regulation of DNA biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048146">
<property type="term" value="P:positive regulation of fibroblast proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000491">
<property type="term" value="P:positive regulation of hepatic stellate cell activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043406">
<property type="term" value="P:positive regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035793">
<property type="term" value="P:positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045840">
<property type="term" value="P:positive regulation of mitotic nuclear division"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043552">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014068">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010863">
<property type="term" value="P:positive regulation of phospholipase C activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032516">
<property type="term" value="P:positive regulation of phosphoprotein phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000379">
<property type="term" value="P:positive regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035025">
<property type="term" value="P:positive regulation of Rho protein signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014911">
<property type="term" value="P:positive regulation of smooth muscle cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048661">
<property type="term" value="P:positive regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032956">
<property type="term" value="P:regulation of actin cytoskeleton organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0014066">
<property type="term" value="P:regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032355">
<property type="term" value="P:response to estradiol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043627">
<property type="term" value="P:response to estrogen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034405">
<property type="term" value="P:response to fluid shear stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042542">
<property type="term" value="P:response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0055093">
<property type="term" value="P:response to hyperoxia"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032526">
<property type="term" value="P:response to retinoic acid"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009636">
<property type="term" value="P:response to toxic substance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061298">
<property type="term" value="P:retina vasculature development in camera-type eye"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071670">
<property type="term" value="P:smooth muscle cell chemotaxis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="5"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR013098">
<property type="entry name" value="Ig_I-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR013151">
<property type="entry name" value="Immunoglobulin"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027288">
<property type="entry name" value="PGFRB"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016243">
<property type="entry name" value="Tyr_kinase_CSF1/PDGF_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR001824">
<property type="entry name" value="Tyr_kinase_rcpt_3_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF07679">
<property type="entry name" value="I-set"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00047">
<property type="entry name" value="ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF500948">
<property type="entry name" value="Beta-PDGF_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000615">
<property type="entry name" value="TyrPK_CSF1-R"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00240">
<property type="entry name" value="RECEPTOR_TYR_KIN_III"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0145">Chemotaxis</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0458">Lysosome</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="23">
<location>
<begin position="1"/>
<end position="32"/>
</location>
</feature>
<feature type="chain" description="Platelet-derived growth factor receptor beta" id="PRO_0000016757">
<location>
<begin position="33"/>
<end position="1106"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="33"/>
<end position="532"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="533"/>
<end position="553"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="554"/>
<end position="1106"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="33"/>
<end position="120"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="129"/>
<end position="210"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="214"/>
<end position="309"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 4">
<location>
<begin position="331"/>
<end position="403"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 5">
<location>
<begin position="416"/>
<end position="524"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="6">
<location>
<begin position="600"/>
<end position="962"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="6">
<location>
<begin position="606"/>
<end position="614"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="6 7">
<location>
<position position="826"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="60">
<location>
<position position="634"/>
</location>
</feature>
<feature type="site" description="Breakpoint for insertion to form PDE4DIP-PDGFRB fusion protein">
<location>
<begin position="527"/>
<end position="528"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form TRIP11-PDGFRB">
<location>
<begin position="527"/>
<end position="528"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form the CEP85L-PDGFRB fusion protein">
<location>
<begin position="558"/>
<end position="559"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="10">
<location>
<position position="562"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="21 26 51">
<location>
<position position="579"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26 51">
<location>
<position position="581"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by ABL1 and ABL2" evidence="3">
<location>
<position position="686"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="26">
<location>
<position position="716"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="18 26">
<location>
<position position="740"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="10 18 21 28 44">
<location>
<position position="751"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="10">
<location>
<position position="763"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="10 18 21 26">
<location>
<position position="771"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="10">
<location>
<position position="775"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="10">
<location>
<position position="778"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="10 18 26 28 44">
<location>
<position position="857"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by ABL1 and ABL2" evidence="3">
<location>
<position position="934"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by ABL1 and ABL2" evidence="3">
<location>
<position position="970"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="10 20 26">
<location>
<position position="1009"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="10 20 21 26">
<location>
<position position="1021"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="45"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="34">
<location>
<position position="89"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="34">
<location>
<position position="103"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="34">
<location>
<position position="215"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="34">
<location>
<position position="230"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="34">
<location>
<position position="292"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="34">
<location>
<position position="307"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="354"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="371"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="468"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="479"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5 34">
<location>
<begin position="54"/>
<end position="100"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5 34">
<location>
<begin position="149"/>
<end position="190"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5 34">
<location>
<begin position="235"/>
<end position="291"/>
</location>
</feature>
<feature type="disulfide bond" evidence="5">
<location>
<begin position="436"/>
<end position="508"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056008" evidence="59">
<original>VESGYVRLLGEVGTLQFAELHRSRTL</original>
<variation>RAATCGSWERWAHYNLLSCIGAGHCR</variation>
<location>
<begin position="311"/>
<end position="336"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056009" evidence="59">
<location>
<begin position="337"/>
<end position="1106"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17110944." id="VAR_034377" evidence="29">
<original>I</original>
<variation>F</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17853027." id="VAR_035125" evidence="24">
<original>S</original>
<variation>F</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34586048." id="VAR_042027" evidence="29">
<original>E</original>
<variation>K</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229558." id="VAR_049717">
<original>P</original>
<variation>S</variation>
<location>
<position position="345"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41287110." id="VAR_042028" evidence="29">
<original>E</original>
<variation>K</variation>
<location>
<position position="485"/>
</location>
</feature>
<feature type="sequence variant" description="In IMF1; dbSNP:rs367543286." id="VAR_069925" evidence="40">
<original>R</original>
<variation>C</variation>
<location>
<position position="561"/>
</location>
</feature>
<feature type="sequence variant" description="In KOGS; dbSNP:rs863224946." id="VAR_075865" evidence="43">
<original>P</original>
<variation>R</variation>
<location>
<position position="584"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric adenocarcinoma sample; somatic mutation." id="VAR_042029" evidence="29">
<original>Y</original>
<variation>H</variation>
<location>
<position position="589"/>
</location>
</feature>
<feature type="sequence variant" description="In IBGC4; no effect on protein abundance; loss of PDGF beta receptor activity; dbSNP:rs397509381." id="VAR_069320" evidence="39 42 47">
<original>L</original>
<variation>P</variation>
<location>
<position position="658"/>
</location>
</feature>
<feature type="sequence variant" description="In IMF1; dbSNP:rs144050370." id="VAR_069926" evidence="41">
<original>P</original>
<variation>T</variation>
<location>
<position position="660"/>
</location>
</feature>
<feature type="sequence variant" description="In PENTT; gain of function in protein tyrosine kinase activity; shows ligand-independent constitutive signaling." id="VAR_075866" evidence="46">
<original>V</original>
<variation>A</variation>
<location>
<position position="665"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35322465." id="VAR_042030" evidence="29">
<original>N</original>
<variation>Y</variation>
<location>
<position position="718"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast infiltrating ductal carcinoma sample; somatic mutation." id="VAR_042031" evidence="29">
<original>T</original>
<variation>I</variation>
<location>
<position position="882"/>
</location>
</feature>
<feature type="sequence variant" description="In IBGC4; decreased protein abundance; no effect on receptor activity; decreased PDGF signaling pathway; dbSNP:rs397509382." id="VAR_069321" evidence="39 42 47">
<original>R</original>
<variation>W</variation>
<location>
<position position="987"/>
</location>
</feature>
<feature type="sequence variant" description="In IBGC4; no effect on protein abundance; no effect on receptor activity; decreased PDGF signaling pathway." id="VAR_075395" evidence="42 47">
<original>E</original>
<variation>V</variation>
<location>
<position position="1071"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity; when associated with F-581. Strongly reduces interaction with SRC family kinases. No effect on interaction with GRB10." evidence="8 51">
<original>Y</original>
<variation>F</variation>
<location>
<position position="579"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity; when associated with F-579. No effect on interaction with GRB10." evidence="8 51">
<original>Y</original>
<variation>F</variation>
<location>
<position position="581"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity." evidence="18 31 32">
<original>K</original>
<variation>A</variation>
<variation>R</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect neither on interaction with GRB10 and RASA1 nor on phosphatidylinositol 3-kinase activity." evidence="8 18">
<original>Y</original>
<variation>F</variation>
<location>
<position position="716"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces up-regulation of cell proliferation; when associated with F-751. Strongly decreases phosphatidylinositol 3-kinase activity. No effect on interaction with GRB10 and RASA1." evidence="8 18 19 36">
<original>Y</original>
<variation>F</variation>
<location>
<position position="740"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces up-regulation of cell proliferation; when associated with F-740. Abolishes phosphatidylinositol 3-kinase activity and interaction with NCK1, and slightly reduces interaction with RASA1. No effect on interaction with GRB10." evidence="8 18 19 27 36 53">
<original>Y</original>
<variation>F</variation>
<location>
<position position="751"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with RASA1 and on phosphatidylinositol 3-kinase activity." evidence="18">
<original>Y</original>
<variation>F</variation>
<location>
<position position="763"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with GRB10. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity." evidence="8 18 19">
<original>Y</original>
<variation>F</variation>
<location>
<position position="771"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with RASA1 and on phosphatidylinositol 3-kinase activity." evidence="18">
<original>Y</original>
<variation>F</variation>
<location>
<position position="775"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces expression levels." evidence="18">
<original>Y</original>
<variation>F</variation>
<location>
<position position="778"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces kinase activity. No effect on interaction with GRB10. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity." evidence="8 18 27 32">
<original>Y</original>
<variation>F</variation>
<location>
<position position="857"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with GRB10. Abolishes interaction with PLCG1; when associated with F-1021." evidence="8 20 52">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1009"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces up-regulation of cell proliferation. Abolishes interaction with PLCG1; when associated with F-1009. No effect on interaction with GRB10." evidence="8 20 30 36">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1021"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA36427." ref="2" evidence="60">
<original>E</original>
<variation>D</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="40"/>
<end position="43"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="50"/>
<end position="58"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="61"/>
<end position="64"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="70"/>
<end position="75"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="81"/>
<end position="87"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="92"/>
<end position="94"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="96"/>
<end position="101"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="114"/>
<end position="119"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="132"/>
<end position="135"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="136"/>
<end position="141"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="145"/>
<end position="147"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="158"/>
<end position="164"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="175"/>
<end position="177"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="178"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="185"/>
<end position="194"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="197"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="204"/>
<end position="208"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="217"/>
<end position="221"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="223"/>
<end position="226"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="231"/>
<end position="239"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="241"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="252"/>
<end position="255"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="261"/>
<end position="265"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="267"/>
<end position="270"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="271"/>
<end position="280"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="287"/>
<end position="295"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="296"/>
<end position="299"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="300"/>
<end position="311"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="530"/>
<end position="556"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2L6W"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3MJG"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10454568"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10805725"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10821867"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11297552"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11331881"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11567151"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11882663"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12181402"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12907457"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1313434"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1314164"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1375321"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1396585"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14966296"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15087372"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15340161"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15492236"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15902258"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1653029"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1709159"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17620338"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1846866"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20494825"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20529858"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20534510"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21098708"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21679854"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21733313"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21938754"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23255827"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23731537"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23731542"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24065723"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25454926"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2550144"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2554309"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26279204"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26599395"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2835772"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2850496"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7679113"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7685273"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7691811"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7692233"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8195171"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8302579"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8940081"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9373237"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9989826"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18593464"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000305"/>
<sequence length="1106" mass="123968" checksum="038C15E531D6E89D" modified="1989-07-01" version="1" precursor="true">
MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTFVLTCSGSAPV
VWERMSQEPPQEMAKAQDGTFSSVLTLTNLTGLDTGEYFCTHNDSRGLETDERKRLYIFV
PDPTVGFLPNDAEELFIFLTEITEITIPCRVTDPQLVVTLHEKKGDVALPVPYDHQRGFS
GIFEDRSYICKTTIGDREVDSDAYYVYRLQVSSINVSVNAVQTVVRQGENITLMCIVIGN
EVVNFEWTYPRKESGRLVEPVTDFLLDMPYHIRSILHIPSAELEDSGTYTCNVTESVNDH
QDEKAINITVVESGYVRLLGEVGTLQFAELHRSRTLQVVFEAYPPPTVLWFKDNRTLGDS
SAGEIALSTRNVSETRYVSELTLVRVKVAEAGHYTMRAFHEDAEVQLSFQLQINVPVRVL
ELSESHPDSGEQTVRCRGRGMPQPNIIWSACRDLKRCPRELPPTLLGNSSEEESQLETNV
TYWEEEQEFEVVSTLRLQHVDRPLSVRCTLRNAVGQDTQEVIVVPHSLPFKVVVISAILA
LVVLTIISLIILIMLWQKKPRYEIRWKVIESVSSDGHEYIYVDPMQLPYDSTWELPRDQL
VLGRTLGSGAFGQVVEATAHGLSHSQATMKVAVKMLKSTARSSEKQALMSELKIMSHLGP
HLNVVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQHHSDKRRPPSAELYSNAL
PVGLPLPSHVSLTGESDGGYMDMSKDESVDYVPMLDMKGDVKYADIESSNYMAPYDNYVP
SAPERTCRATLINESPVLSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLV
KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNSLYTTLSDVWSFGILLWEIFTLG
GTPYPELPMNEQFYNAIKRGYRMAQPAHASDEIYEIMQKCWEEKFEIRPPFSQLVLLLER
LLGEGYKKKYQQVDEEFLRSDHPAILRSQARLPGFHGLRSPLDTSSVLYTAVQPNEGDND
YIIPLPDPKPEVADEGPLEGSPSLASSTLNEVNTSSTISCDSPLEPQDEPEPEPQLELQV
EPEPELEQLPDSGCPAPRAEAEDSFL
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>